Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
about
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerBreast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures.Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome.Effects of age on the detection and management of breast cancer.Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarkerMiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?How interacting pathways are regulated by miRNAs in breast cancer subtypes.The complexity of microRNAs in human cancer.Identification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine.MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.The role of the UTS2 gene polymorphisms and plasma Urotensin-II levels in breast cancer.miR-133a, directly targeted USP39, suppresses cell proliferation and predicts prognosis of gastric cancer.Enhanced motility and proliferation by miR-10b/FUT8/p-AKT axis in breast cancer cells.
P2860
Q26801108-ED62DE04-02DD-4FC6-877C-F23970457F76Q30248838-E3E37B1D-E26D-45EA-9616-54389A85D04DQ33602610-A834B77C-6C89-403D-B395-5A2B7B1C6B38Q34450694-19BF0059-40D2-4DBC-9325-409A4B72894DQ34477879-CAAD33AF-A2C5-4C0D-8E02-F61C66463D3FQ35203556-4737A7BF-E58A-4EB4-A27B-36C22772DACCQ35247522-45726674-70C9-4F4E-B2E8-68D9C7B74E3CQ35682549-B82D1B30-E5BB-4657-A08C-BD4455DF3F32Q36276533-77764B22-5914-4A83-B593-6EFD495E20DCQ37187237-AC9C6F4F-1529-46B7-BF72-8CC674B1A152Q37499268-A97959B1-B842-4671-9946-42AC3E6F7E1CQ40887298-3BD341B8-2D7A-4C0A-9102-10541CFEC289Q53224729-E4EAAA76-60C0-47C3-9A43-C18E1FE25464Q55040342-BDC37E10-96D5-4954-A29E-CA46EB2E560CQ55709884-1461359A-83F3-42D3-881C-402B8A44C625
P2860
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
@ast
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
@en
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
@nl
type
label
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
@ast
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
@en
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
@nl
prefLabel
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
@ast
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
@en
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
@nl
P2860
P356
P1476
Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?
@en
P2093
Gerasimos Socrates Christodoulatos
P2860
P356
10.5306/WJCO.V5.I2.71
P577
2014-05-01T00:00:00Z